The investigators aim in this study to investigate the effect of intravitreal triamcinolone acetonide injection on the development of macular edema and the progression of diabetic retinopathy. Whether this injection hastens cataract surgery results or not. The investigators will categorize the participants into two groups: the case group who will receive the injection at the end of the surgery, and the control group who will have routine cataract surgery with no extra injections.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in central subfield mean macular thickness as a measurement of efficacy
Timeframe: T0_ 1 month- T1_ 3 months- T2_ 6 months postoperatively]
Change in diabetic retinopathy grade as a measurement of efficacy
Timeframe: T0: 1 month- T2: 3 months- T3: 6 months postoperatively